NCT06947213Recruiting
Orthorexia Nervosa in Postmenopausal Osteoporosis
Fragile Bones, Strong Obsessions: A Controlled Study on Orthorexia Nervosa, Body Image and Mood in Postmenopausal Women With Osteoporosis
Source: ClinicalTrials.gov · Last updated 27 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 128 (estimated)
- First submitted
- 20 Apr 2025
- Start date
- 20 Apr 2025
- Primary completion date
- 20 May 2025
- Lead sponsor
- Beylikduzu State Hospital
- Diseases
- Osteoporosis
- NCT number
- NCT06947213
What you commit to
- Study type: Observational
- Planned participants: 128
- From 20 Apr 2025 to the primary completion date, 20 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of medications affecting mood.
Other illness
- Diagnosed psychiatric disorders.
- Cognitive impairment.
- Presence of malignancy.
- Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
Other
- Refusal to participate in the study.
- Use of glucocorticoids.
Who the study is looking for
- Women between 55-75 years
- Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
- Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
- Willingness to participate and provision of written informed consent.
Age in the registry: 55 years to 75 years · Sex: Female
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beylikdüzü State Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.